Academic Journal

Differential Expression of HIF1A, EPAS1, and VEGF Genes in Benign and Malignant Ovarian Neoplasia

التفاصيل البيبلوغرافية
العنوان: Differential Expression of HIF1A, EPAS1, and VEGF Genes in Benign and Malignant Ovarian Neoplasia
المؤلفون: Monika Englert-Golon, Małgorzata Tokłowicz, Aleksandra Żbikowska, Stefan Sajdak, Małgorzata Kotwicka, Mirosław Andrusiewicz
المصدر: Cancers; Volume 14; Issue 19; Pages: 4899
بيانات النشر: Multidisciplinary Digital Publishing Institute
سنة النشر: 2022
المجموعة: MDPI Open Access Publishing
مصطلحات موضوعية: ovarian cancer, prognostic biomarker, hypoxia-inducible factor 1-alpha (HIF1A), endothelial PAS domain protein 1/hypoxia inducible factor 2-alpha (HIF2A/EPAS1), vascular endothelial growth factor A (VEGFA)
الوصف: Ovarian cancer (OC) has the highest mortality rate of all gynecological malignancies. Moreover, at the time of the first clinical manifestation, most patients have an advanced stage of the disease. Our study examined differences in mRNA levels of hypoxia-inducible factor 1-alpha (HIF1A); endothelial PAS domain protein 1, also known as hypoxia-inducible factor 2-alpha (HIF2A/EPAS1); and vascular endothelial growth factor A (VEGFA) between cancerous tissue, benign hyperplastic changes in the ovary, and normal tissue. Our cohorts consisted of 52 patients diagnosed with OC (n = 55), benign non-cancerous changes (n = 21), and normal tissue samples (n = 38). The mRNA expression level was evaluated using RT-qPCR. We found that gene expression changes were visible not only in the case-control study, but also along with changes in severity. Additionally, the gene expression was differentiated in age, BMI, menopausal status, and the number of comorbidy-related groups. Furthermore, our findings demonstrate that analyzing the correlation between genes is essential. In a case-to-case and case-to-control study, we observed disturbances in the expression levels of interdependent genes. Our findings suggest that mutual association in the expression of both HIF1A and HIF2A/EPAS1 with VEGFA has prognostic importance for patients with OC. Our observations may help identify patients for clinical trials aimed at inhibiting the hypoxia-induced neovascularization-dependent pathways.
نوع الوثيقة: text
وصف الملف: application/pdf
اللغة: English
Relation: https://dx.doi.org/10.3390/cancers14194899
DOI: 10.3390/cancers14194899
الاتاحة: https://doi.org/10.3390/cancers14194899
Rights: https://creativecommons.org/licenses/by/4.0/
رقم الانضمام: edsbas.A737F37F
قاعدة البيانات: BASE